Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Ecnoglutide in Non-Diabetic Adults With Obesity or Overweight
NCT07192263Phase 3Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Peptides
01
Overview
A Phase 3 trial of ecnoglutide in obesity, Overweight, sponsored by HK inno.N Corporation. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
ecnoglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07192263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07192263.